Drug Information

Drug General Information
Drug ID
D0X9WC
Former ID
DIB006762
Drug Name
ISIS-DMPK
Drug Type
Antisense drug
Indication Myotonic dystrophy [ICD10:G71.1] Phase 1/2 [525022]
Target and Pathway
Target(s) mRNA of DMPK Target Info [551943]
References
Ref 525022ClinicalTrials.gov (NCT02312011) A Safety andTolerability Study of Multiple Doses of ISIS-DMPKRx in Adults With Myotonic Dystrophy Type 1. U.S. National Institutes of Health.
Ref 551943Clinical pipeline report, company report or official report of ISIS Pharmaceuticals.